Abstract:Approximately 30% of patients with Epstein-Barr virus (EBV)-positive advanced nasopharyngeal carcinoma (NPC) display chemoresistance to cisplatin-based regimens, but the underlying mechanisms are unclear. The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1), a functional homologue of the tumor necrosis factor receptor family, contributes substantially to the oncogenic potential of EBV through the activation of multiple signaling pathways, and it is closely associated with a poorer prognosis for NPC. Recent studies show that EBV infection can induce the expression of many cellular miRNAs, including microRNA-21, a biomarker for chemoresistance. However, neither a link between LMP1 expression and miR-21 upregulation nor their cross talk in affecting chemoresistance to cisplatin have been reported. Here, we observed that stable LMP1-transformed NPC cells were less sensitive to cisplatin treatment based on their proliferation, colony formation, the IC50 value of cisplatin and the apoptosis index. Higher levels of miR-21 were found in EBV-carrying and LMP1-positive cell lines, suggesting that LMP1 may be linked to miR-21 upregulation. These data were confirmed by our results that exogenous LMP1 increased miR-21 in both transiently and stably LMP1-transfected cells, and the knock down of miR-21 substantially reversed the resistance of the NPC cells to cisplatin treatment. Moreover, the proapoptotic factors programmed cell death 4 (PDCD4) and Fas ligand (Fas-L), which were negatively regulated by miR-21, were found to play an important role in the program of LMP1-dependent cisplatin resistance. Finally, we demonstrated that LMP1 induced miR-21 expression primarily by modulating the PI3K/AKT/FOXO3a signaling pathway. Taken together, we revealed for the first time that viral LMP1 triggers the PI3K/Akt/FOXO3a pathway to induce human miR-21 expression, which subsequently decreases the expression of PDCD4 and Fas-L, and results in chemoresistance in NPC cells.

Epstein-Barr Virus Lmp1 Initiates Cell Proliferation and Apoptosis Inhibition Via Regulating Expression of Survivin in Nasopharyngeal Carcinoma

Epstein-Barr Virus Lmp1 Triggers The Expression Of Inhibitor Of Apoptosis Protein Survivin Via Nf Kappa B And Ap-1 Signaling Pathways

Epstein-Barr virus LMP1 triggers the expression of inhibitor of apoptosis protein survivin via NF kappa B and AP-1 signaling pathways in nasopharyngeal carcinoma

Regulation of Survivin and CDK4 by Epstein-Barr Virus Encoded Latent Membrane Protein 1 in Nasopharyngeal Carcinoma Cell Lines

Epstein-Barr Virus Oncoprotein LMP1 Mediates Survivin Upregulation by P53 Contributing to G1/S Cell Cycle Progression in Nasopharyngeal Carcinoma

Cells in G 2 /M Phase Increased in Human Nasopharyngeal Carcinoma Cell Line by EBV-LMP1 Through Activation of NF- Κ B and AP-1

Role of Epstein-Barr Virus Encoded Latent Membrane Protein 1 in the Carcinogenesis of Nasopharyngeal Carcinoma.

The Epstein-Barr Virus Encoded Latent Membrane Protein 1 Promotes Nuclear Factor-kappa B Activity in a Nasopharyngeal Carcinoma Cell Line

Epstein-Barr Virus Nuclear Antigen 1 (ebna1) Confers Resistance to Apoptosis in Ebv-Positive B-Lymphoma Cells Through Up-Regulation of Survivin

Epstein–Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-κB p65 in human nasopharyngeal carcinoma cells

Epstein-Barr Virus Encoded Latent Membrane Protein 1 Regulates Mtor Signaling Pathway Genes Which Predict Poor Prognosis of Nasopharyngeal Carcinoma

Study of Apoptosis Regulated by Epstein-Barr Virus Encoded Latent Membrane Protein 1 Using Apoptosis cDNA Expression Array

Epstein-Barr Virus LMP1 Status in Relation to Apoptosis, P53 Expression and Leucocyte Infiltration in Nasopharyngeal Carcinoma.

Epstein-Barr Virus Latent Membrane Protein1(LMP1) Activated Ets-1 Expression Mediated by ERK in Nasopharyngeal Cell Line

Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial-Mesenchymal Transition and Increases the Number of Side Population Stem-Like Cancer Cells in Nasopharyngeal Carcinoma.

Epstein-Barr Virus Latent Membrane Protein 1 Induces Telomerase Activity of Nasopharyngeal Epithelial Cells Through NFκB

siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.

[Epstein-Barr Virus Latent Membrane Protein 1 Induces the Telomerase Activity in Human Nasopharyngeal Epithelial Cells].

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Promotes Extracellular Vesicle Secretion Through Syndecan-2 and Synaptotagmin-Like-4 in Nasopharyngeal Carcinoma Cells

Latent Membrane Protein 1 of Epstein-Barr Virus Regulates P53 Phosphorylation Through MAP Kinases

Epstein-Barr Virus_Encoded LMP1 Upregulates Microrna-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L.